Yahoo Finance28d
Allurion Announces Positive Topline Results From AUDACITY Trial
NATICK, Mass., January 08, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced topline results from the AUDACITY Food & Drug ...
Business Insider29d
Allurion announces AUDACITY trial meets one co-primary endpoint, misses other
Allurion Technologies (ALUR) announced topline results from the AUDACITY FDA pivotal trial evaluating the safety and efficacy of the Allurion Balloon. The AUDACITY trial is an open-label ...
Business Wire12d
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...
Nasdaq13d
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today ...
Nasdaq28d
Allurion Announces Positive Topline Results From AUDACITY Trial
At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects Low rate of serious adverse events supports favorable ...
Stockhouse12d
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...